Catheter ablation reduces atrial fibrillation recurrence compared to anti-arrhythmic drugs in paroxysmal and persistent cases
Catheter Ablation Shows Lower Recurrence Rates for Atrial Fibrillation
This systematic review and meta-analysis of randomized controlled trials compares catheter ablation to anti-arrhythmic drugs (AAD) for manag…
A review of clinical trials suggests catheter ablation may lead to lower heart rhythm recurrence rates compared to anti-arrhythmic drugs.
Catheter ablation reduces serious adverse events and unplanned hospitalizations by 20% and 47% in atrial fibrillation
Catheter Ablation Shows Lower Risk for Atrial Fibrillation Patients
This meta-analysis of randomized trials evaluates catheter ablation versus antiarrhythmic drugs for atrial fibrillation management. The anal…
A meta-analysis of randomized trials suggests catheter ablation may lower risks of serious events and unplanned hospital stays for people wi…
Pulsed field ablation beats antiarrhythmic drugs as first-line persistent AF therapy
Pulsed field ablation shows higher success than drugs for heart rhythm
In a randomized trial of 207 patients with previously untreated persistent atrial fibrillation, pulsed field ablation (PFA) achieved 56% tre…
A new trial shows pulsed field ablation provides a much higher success rate than standard drugs for patients with persistent atrial fibrilla…